Vicus Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $267K | Buy |
3,721
+22
| +0.6% | +$1.7K | 0.02% | 227 |
|
|
2025
Q4 | $294K | Sell |
3,699
-3
| -0.1% | -$237 | 0.02% | 219 |
|
|
2025
Q3 | $279K | Sell |
3,702
-398
| -10% | -$27.3K | 0.02% | 237 |
|
|
2025
Q2 | $283K | Sell |
4,100
-47
| -1% | -$3.08K | 0.02% | 226 |
|
|
2025
Q1 | $281K | Buy |
+4,147
| New | +$248K | 0.03% | 197 |
|
|
2024
Q4 | – | Sell |
-4,981
| Closed | -$313K | – | 239 |
|
|
2024
Q3 | $313K | Sell |
4,981
-181
| -4% | -$10.6K | 0.03% | 172 |
|
|
2024
Q2 | $305K | Sell |
5,162
-1,168
| -18% | -$73.1K | 0.03% | 218 |
|
|
2024
Q1 | $505K | Buy |
6,330
+717
| +13% | +$54.8K | 0.05% | 151 |
|
|
2023
Q4 | $443K | Sell |
5,613
-772
| -12% | -$54.9K | 0.04% | 138 |
|
|
2023
Q3 | $446K | Buy |
6,385
+65
| +1% | +$4.61K | 0.05% | 156 |
|
|
2023
Q2 | $437K | Sell |
6,320
-779
| -11% | -$55.4K | 0.05% | 146 |
|
|
2023
Q1 | $528K | Sell |
7,099
-150
| -2% | -$12.6K | 0.06% | 129 |
|
|
2022
Q4 | $676K | Sell |
7,249
-231
| -3% | -$22.3K | 0.08% | 106 |
|
|
2022
Q3 | $713K | Buy |
7,480
+19
| +0.3% | +$1.88K | 0.08% | 119 |
|
|
2022
Q2 | $691K | Sell |
7,461
-1,241
| -14% | -$121K | 0.08% | 122 |
|
|
2022
Q1 | $881K | Sell |
8,702
-721
| -8% | -$75.7K | 0.09% | 113 |
|
|
2021
Q4 | $1.03M | Buy |
+9,423
| New | +$871K | 0.1% | 103 |
|
|
2021
Q2 | – | Sell |
-10,666
| Closed | -$802K | – | 175 |
|
|
2021
Q1 | $802K | Sell |
10,666
-180
| -2% | -$13.1K | 0.1% | 112 |
|
|
2020
Q4 | $741K | Sell |
10,846
-1,637
| -13% | -$106K | 0.09% | 108 |
|
|
2020
Q3 | $729K | Sell |
12,483
-1,834
| -13% | -$114K | 0.1% | 99 |
|
|
2020
Q2 | $930K | Sell |
14,317
-269
| -2% | -$16.9K | 0.14% | 84 |
|
|
2020
Q1 | $865K | Sell |
14,586
-1,392
| -9% | -$92.9K | 0.16% | 80 |
|
|
2019
Q4 | $1.19M | Sell |
15,978
-688
| -4% | -$48.3K | 0.18% | 73 |
|
|
2019
Q3 | $1.05M | Sell |
16,666
-1,451
| -8% | -$86K | 0.15% | 102 |
|
|
2019
Q2 | $987K | Sell |
18,117
-1,116
| -6% | -$60.1K | 0.14% | 103 |
|
|
2019
Q1 | $1.04M | Sell |
19,233
-951
| -5% | -$58.7K | 0.16% | 94 |
|
|
2018
Q4 | $1.32M | Buy |
20,184
+1,365
| +7% | +$102K | 0.24% | 73 |
|
|
2018
Q3 | $1.48M | Buy |
18,819
+2,196
| +13% | +$157K | 0.24% | 71 |
|
|
2018
Q2 | $1.07M | Buy |
16,623
+2,658
| +19% | +$175K | 0.18% | 83 |
|
|
2018
Q1 | $869K | Buy |
13,965
+2,566
| +23% | +$184K | 0.15% | 104 |
|
|
2017
Q4 | $826K | Buy |
11,399
+10
| +0.1% | +$727 | 0.14% | 111 |
|
|
2017
Q3 | $926K | Buy |
11,389
+2,970
| +35% | +$235K | 0.18% | 97 |
|
|
2017
Q2 | $677K | Buy |
8,419
+3,497
| +71% | +$276K | 0.14% | 118 |
|
|
2017
Q1 | $386K | Buy |
4,922
+675
| +16% | +$53.9K | 0.08% | 159 |
|
|
2016
Q4 | $335K | Buy |
+4,247
| New | +$344K | 0.07% | 168 |
|
Other funds holding CVS
VCM
VPM
Vicus Capital's CVS Position: Q1 2026 in Review
Vicus Capital increased its CVS Health (CVS) stake by 0.59% in Q1 2026, buying an estimated $1.7K and bringing the position to 3,721 shares worth $267K. The position accounts for 0.02% of the portfolio, ranked #227.
Vicus Capital first reported a position in CVS in Q4 2016 and has held it in 35 quarters since. The position peaked at $1.48M in Q3 2018. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Vicus Capital held 3,721 shares of CVS Health worth $267K as of Q1 2026.
- Vicus Capital bought 22 CVS Health shares in Q1 2026, an estimated $1.7K.
- CVS Health made up 0.02% of Vicus Capital's portfolio in Q1 2026, its #227 holding.
- Vicus Capital first reported a position in CVS Health in Q4 2016 and has held it in 35 quarters since.
- Vicus Capital's CVS Health position peaked at $1.48M in Q3 2018.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.